Drug Delivery in Cancer Market Size, & Growth Report 2031

Introduction
- Introduction
- Market Scope
  - Market Definition
  - Segments Covered
  - Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2026-2027)
Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
  - Bottom-Up Approach
  - Top-Down Approach
- Market Forecasting
Executive Summary
- Drug Delivery in Cancer Marke"4">
- Market Overview
  - Market Dynamics
    - Drivers
      - Rising global cancer burden
      - Growing adoption of targeted therapies
      - Expansion of biologics and nucleic acid therapeutics
      - Increasing investment in oncology R&D
      - Demand for improved patient outcomes and quality of life
    - Restraints
      - High development and manufacturing costs
      - Stringent regulatory requirements
      - Limited accessibility in emerging markets
      - Stability and formulation challenges
    - Opportunities
      - Growth of precision medicine
      - Expansion of nanoparticle-based drug delivery
      - Rising development of antibody-drug conjugates (ADCs)
      - Increasing adoption of RNA-based therapeutics
      - Emerging markets and healthcare expansion
    - Key Market Trends
      - Nanomedicine becoming a mainstream oncology platform
      - Rapid growth of antibody-drug coi>Increasing integration of artificial intelligence (AI)
      - Development of stimuli-responsive delivery systems
    - Unmet Market Needs
    - Industry Speaks
- Global Drug Delivery in Cancer Market Size & Forecast (2024-2031), By Technology, USD Billion
  - Introduction
  - Nanoparticles
  - Liposomes
  - Antibody-drug Conjugates (ADCs)
  - Polymeric Drug Delivery Systems
  - Other Technologies
- Global Drug Delivery in Cancer Market Size & Forecast (2024-2031), By Route of Administration, USD Billion
  - Introduction
  - Intravenous
  - Oral
  - Subcutaneous
  - Intratumoral
  - Transdermal
  - Other Routes of Administration
- Global Drug Delivery in Cancer Market Size & Forecast (2024-2031), By Cancer Type, USD Billion
  - Introduction
  - Breast Cancer
  - Lung Cancer
  - Colorectal Cancer
  - Prostate Cancer
  - Liver Cancer
  - Ovarian Cancer
  - Pancreatic Cancer
  - Other Cancer Types
- Global Market Size & Forecast (2024-2031), By End User, USD Billion
  
  Introduction
  
  Hospitals
  
  Cancer Treatment Centers
  
  Specialty Clinics
  
  Other End Users

Competitive Landscape

Key Players and their Competitive Positioning

Key Player Comparison

Segment-wise Player Mapping

Market Share Analysis (2025)

Company Categorization Matrix

Dominants/Leaders

New Entrants

Emerging Players

Innovative Players

Key Strategies Assessment, By Player (2023-2026)

New Product Launch/Approval

Partnerships, Agreements, & Collaborations

Mergers & Acquisitions

Geographic Expansion

Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

Johnson & Johnson

Pfizer Inc.

Hoffmann-La Roche Ltd.

Merck & Co., Inc.

AstraZeneca PLC

Novartis AG

AbbVie Inc.

Gilead Sciences, Inc.

Bristol Myers Squibb

Jazz Pharmaceuticals plc

Other Prominent Players

Global Drug Delivery in Cancer Market Size Report Segmented by Technology (Nanoparticles, Liposomes, ADCs), Route of Administration (Intravenous, Oral, Subcutaneous, Intratumoral), Cancer Type (Breast, Lung, Colorectal), End User & Regional Forecast to 2031

Table of Contents

Global Drug Delivery in Cancer Market Size Report Segmented by Technology (Nanoparticles, Liposomes, ADCs), Route of Administration (Intravenous, Oral, Subcutaneous, Intratumoral), Cancer Type (Breast, Lung, Colorectal), End User & Regional Forecast to 2031

Table of Contents

Related Reports

Global Bone Void Fillers Market Size & Trends Report Segmented by Type (Demineralized Bone...

Global Bioconjugation Market Size & Trends Report Segmented by Product and Service (Reagen...

Global Generative AI in Healthcare Market Size & Trends Report Segmented by Application (D...